Tianxin Pharmaceuticals (603235.SH) released its first quarter financial results, with a net profit attributable to shareholders of 2.19 billion yuan, an increase of 48.13% year-on-year.

Zhitong Finance and Economics APP News, Tianxin Pharmaceutical (603235.SH) released the first quarter report of 2025, during the reporting period, the company achieved a revenue of 619 million yuan, a year-on-year increase of 25.16%; the net profit attributable to the mother was 219 million yuan, a year-on-year increase of 48.13%; the non-net profit was 209 million yuan, a year-on-year increase of 53.30%. Basic earnings per share were 0.50 yuan.